Dedicated computer-aided detection software for automated 3D breast ultrasound; an efficient tool for the radiologist in supplemental screening of women with dense breasts by Zelst, J.C.M. van et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/192112
 
 
 
Please be advised that this information was generated on 2019-06-01 and may be subject to
change.
BREAST
Dedicated computer-aided detection software for automated 3D breast
ultrasound; an efficient tool for the radiologist in supplemental
screening of women with dense breasts
Jan C. M. van Zelst1 & Tao Tan1 & Paola Clauser2 & Angels Domingo3 & Monique D. Dorrius4 & Daniel Drieling5 &
Michael Golatta6 & Francisca Gras3 & Mathijn de Jong7 & Ruud Pijnappel8 & Matthieu J. C. M. Rutten7 &
Nico Karssemeijer1 & Ritse M. Mann1
Received: 14 September 2017 /Revised: 21 November 2017 /Accepted: 21 December 2017 /Published online: 7 February 2018
# The Author(s) 2018. This article is an open access publication
Abstract
Objectives To determine the effect of computer-aided-detection (CAD) software for automated breast ultrasound (ABUS) on
reading time (RT) and performance in screening for breast cancer.
Material and methods Unilateral ABUS examinations of 120 women with dense breasts were randomly selected from a
multi-institutional archive of cases including 30 malignant (20/30 mammography-occult), 30 benign, and 60 normal
cases with histopathological verification or ≥ 2 years of negative follow-up. Eight radiologists read once with (CAD-
ABUS) and once without CAD (ABUS) with > 8 weeks between reading sessions. Readers provided a BI-RADS score
and a level of suspiciousness (0-100). RT, sensitivity, specificity, PPV and area under the curve (AUC) were compared.
Results Average RT was significantly shorter using CAD-ABUS (133.4 s/case, 95% CI 129.2-137.6) compared with ABUS
(158.3 s/case, 95% CI 153.0-163.3) (p < 0.001). Sensitivity was 0.84 for CAD-ABUS (95% CI 0.79-0.89) and ABUS (95% CI
0.78-0.88) (p = 0.90). Three out of eight readers showed significantly higher specificity using CAD. Pooled specificity (0.71,
95% CI 0.68-0.75 vs. 0.67, 95% CI 0.64-0.70, p = 0.08) and PPV (0.50, 95% CI 0.45-0.55 vs. 0.44, 95% CI 0.39-0.49, p = 0.07)
were higher in CAD-ABUS vs. ABUS, respectively, albeit not significantly. Pooled AUC for CAD-ABUS was comparable with
ABUS (0.82 vs. 0.83, p = 0.53, respectively).
Conclusion CAD software for ABUS may decrease the time needed to screen for breast cancer without compromising the
screening performance of radiologists.
Key Points
• ABUS with CAD software may speed up reading time without compromising radiologists’ accuracy.
• CAD software for ABUS might prevent non-detection of malignant breast lesions by radiologists.
• Radiologists reading ABUS with CAD software might improve their specificity without losing sensitivity.
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Abbreviations
ABUS Automated breast ultrasound
ABVS Automated breast volume scanner
AFROC Alternative free-response receiver-operator
characteristics
ANOVA Analysis Of variance
AUC Area under the ROC curve
CAD Computer-aided detection
FFDM Full-field digital mammography
GEE Generalised estimation equation
HER2 Human epidermal growth factor receptor 2 status
HR Hormone receptor status
IRB Institutional review board
LOS Level Of suspiciousness
MinIP Minimum intensity projection
MIP Maximum intensity projection
MRI Magnetic resonance imaging
MRMC Multiple reader multiple case
PPV Positive predictive value
ROC Receiver-operator characteristics
RT Reading time
US Ultrasound
WBUS Whole-breast ultrasound
Introduction
In mammographic screening the sensitivity in women with
extremely dense breasts is only 61% [1]. A four times higher
interval cancer rate is reported for these women compared
with women with fatty breasts [1]. Supplemental ultrasound
(US) is an effective imaging method to detect mammography-
negative early stage invasive breast cancer in women with
heterogeneously and extremely dense breasts [2–4], thus re-
ducing the frequency of symptomatic interval carcinomas [5].
This is crucial, because detection of breast cancer at an early
stage substantially improves prognosis, even when using
modern therapy regimes [6]. This explains the rationale and
ratification of the breast density inform laws in many states in
the USA [7, 8] and the introduction of supplemental whole-
breast ultrasound (WBUS) screening in Austria [9].
Performing supplemental WBUS with handheld devices
has limitations. It is relatively time consuming and difficult
to compare to prior examinations. Furthermore, handheld
WBUS screening is operator dependent and should therefore
be performed by trained sonographists, which consequently
requires substantial resources [10]. Automated 3D breast US
(ABUS) devices have been developed to improve the repro-
ducibility of WBUS and decrease the need for highly trained
sonographers. An ABUS examination consists of a set of large
3D volumes for each breast acquired with a wide automatical-
ly driven linear array transducer. The number of volumes de-
pends on the size of the breast and in large breasts up to five
volumes per breast are acquired. There is mounting evidence
that, similar to handheld ultrasound, ABUS devices also lead
to the detection of mammography-negative invasive breast
cancers [11–15].
A downside of supplemental ultrasound screening is the
detection of mammographically occult benign lesions that
warrant histological verification [11, 13, 16], thus decreasing
the specificity of screening. ABUS devices do allow storage
of full breast ultrasound volumes, which enables the radiolo-
gist to compare examinations with relevant priors, which is
expected to improve specificity in follow-up examinations.
Due to the large number of images in the scan, reading a
full ABUS examination can be lengthy and cancers may easily
be overlooked [12]. Computer-aided detection (CAD) soft-
ware for ABUS has been developed to aid radiologists in the
interpretation of ABUS studies [17]. CAD software should
reduce the reading time of supplemental ABUS and may have
the potential to improve the screening performance of radiol-
ogists. To investigate the effectiveness of this approach, we
investigated the effect of commercially available CAD soft-
ware for ABUS on the reading time and screening perfor-
mance of breast radiologists.
Materials and methods
The need for informed consent for this study was waived by
the institutional review board (IRB).
ABUS acquisitions
ABUS examinations were performed with ACUSON S2000
Automated Breast Volume Scanner systems (Siemens,
Erlangen, Germany). This ABUS system acquires 3D B-
mode ultrasound volumes over an area of 154 mm ×
156 mm using a mechanically driven linear array transducer
(14L5). Adequate depth and focus can be obtained using
predefined settings for different breast cup sizes. All ABUS
examinations were performed by technicians. To ensure cov-
erage of the entire breast two to five overlapping acquisitions
were performed at predefined locations. The number of acqui-
sitions depends on the size of the breasts and the possibility to
compress the breasts. Per acquisition 318 slices of 0.5 mm
thickness are obtained. A dedicated ABUSworkstation recon-
structs the transverse slices into a 3D volume that can be read
in a multiplanar hanging, also showing sagittal and coronal
reconstructions.
Data and gold standard
Cases were selected from a large multi-institutional imaging
archive that consisted of 2158 ABUS examinations in 1086
women acquired between August 2010 and February 2015
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from screening programmes for women at average, interme-
diate, and high risk and symptomatic women. For each wom-
an a full-field digital mammography (FFDM) examination
was also available.
To select only cases with high breast density, breast
density was determined using an automated volumetric
software package (Volpara Density, Matakina Ltd.
Wellington, New Zealand) on 1657 available unprocessed
FFDM images. For 501 examinations, where unprocessed
FFDM images were not available, breast density was vi-
sually assessed according to the BIRADS lexicon.
Examinations of 115 women with a history of breast sur-
gery were excluded; 1187 unilateral examinations of
breasts in 715 women were scored as Volpara Density
Grade 3 and 4 or BIRADS density categories C or D.
We categorised these dense cases as Bnormal^ (n = 919),
Bbenign^ (n = 140), or Bmalignant^ (n = 128) based on
radiology and pathology reports from histopathological
examinations. BNormal^ and non-biopsied Bbenign^ cases
were only considered if at least 2 years of negative
follow-up was available. Subsequently, from these women
with dense breasts, we included all cases with a
mammography-negative malignant lesion (n = 20), ten
randomly selected malignant cases that were positive on
both mammography and ABUS, 30 biopsied benign cases
and 60 Bnormal^ cases in the study data set. The study
data set thus consisted of 120 unilateral ABUS evalua-
tions, yielding a total of 375 ABUS volumes.The selected
cases were anonymised and stripped from information
such as age, study date, and imaging institute. All lesions
were annotated by a breast imaging researcher with > 3
years of experience with ABUS based on pathology and
radiology reports. These annotations served as the ground
truth for observer and CAD software detect ion
performance.
CAD software and reading workstation
A prototype workstation was designed and developed specif-
ically for the task of high-throughput ABUS screening in this
observer study (MeVis Medical Solutions, Bremen,
Germany). In this prototype, each user action was logged with
time stamps that were subsequently used to estimate the time
spent per case. Commercially developed CAD software
(QVCAD, Qview Medical Inc., Los Altos, CA) was integrat-
ed into this workstation. This CAD software is designed to
detect suspicious region candidates in an ABUS volume and
mark them with so-called CAD marks (Fig. 1). In addition,
QVCAD software provides an Bintelligent^ minimum inten-
sity projection (MinIP) of the breast tissue in a 3D ABUS
volume that can be used for rapid navigation through ABUS
scans and enhances possible suspicious regions. The number
of CAD marks displayed can be adjusted by setting the
average number of false-positive CAD marks per ABUS vol-
ume. In this study, we chose the default setting of one false-
positive CAD mark per ABUS volume.
Readers
Seven breast radiologists and one gynaecologist specialised in
breast imaging were invited to participate in this study. By
inviting readers from different institutes and countries we
aimed to increase the applicability of our results to breast
imaging practices in different countries, realising that different
readers might have slightly varying standards and customs. In
some countries, also other clinicians are involved in
interpreting breast-imaging examinations. Therefore, we also
invited a non-radiologist (gynaecologist) who specialises in
breast imaging with approximately 10 years of experience in
breast ultrasound and mammography and 8 years of experi-
ence with ABUS. Experience with breast imaging for reader
one to reader eight was 7, 10, 4, 8, 8, 20, 4, and 20 years and
specifically with ABUS was 5, 8, 0, 5, 5, 5, 0, and 0 years,
respectively.
Study design
All eight readers evaluated all cases twice in two separate
reading sessions in an independent crossover multi-reader-
multi-case (MRMC) study. In each session half of the
ABUS cases were read conventionally and half of the cases
were read using a CAD-based workflow designed for this
study. We counterbalanced the reading modes and changed
the case order by randomisation for each reader per reading
session. The reading sessions were at least 8 weeks apart (av-
erage 11.0 weeks, range 8.3-13.1) to further minimise any
effect of memory bias.
Standard ABUS reading was performed in a multiplanar
hanging without CAD software. CAD-based reading was
performed according to specific instructions of a two-step
reading protocol. The first step was to evaluate all CAD
marks and dark spots on the MinIP in a case. Subsequently,
readers were instructed to scan the coronal reconstruction
of each ABUS view in a hanging protocol where coronal
reconstructions of all ABUS views of a breast are simulta-
neously shown.
The readers performed a training session of 20 cases to
become familiar with the workstation, reading protocol, and
CAD software. Readers were given a rough estimate (10-
30%) of the prevalence of cancer in the study data set because
the criteria for a recall may vary between radiologists who, as
in our study, work at different institutes and in different coun-
tries [18] and may depend on the prevalence of cancers they
expect.
In both CAD-based and conventional reading the readers
were instructed to mark and rate lesions by placing a finding
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marker and subsequently determine a BI-RADS assessment
score. Because a quasi-continuous linear scale is required to
perform receiver-operating characteristic (ROC) analysis,
readers were also asked to provide a level of suspiciousness
(LOS) score on a scale from 0-100. Note that LOS is not a
probability of malignancy as described in the BI-RADS atlas.
Instead, readers were recommended to use anchor points re-
ferring to the BI-RADS scores with LOS values of 21, 41, 61,
and 81 corresponding to the BI-RADS 1/2, 2/3, 3/4, and 4/5
transitions.
Statistical analysis
We determined the sensitivity, specificity, and positive pre-
dictive value (PPV) in both reading modes based on BI-
RADS scores and compared these parameters per reader
using paired McNemar’s and chi-square tests with
bootstrapping (1000 samples) to determine the 95% confi-
dence intervals (CI) for individual readers and generalised
estimation equation (GEE) for pooled data to correct for
repeated measurements. An examination was considered
positive if a BI-RADS 3 score (and its anchor point equiv-
alent of 41 on the LOS scale) or higher was given.
Furthermore, we determined the area under the curve
(AUC) and 95 % CI using an alternative free-response re-
ceiver-operating characteristics (AFROC) [19, 20]. For these
analyses, when multiple findings were present in a case, the
finding with the highest rating was used. Ratings in malig-
nant cases where the marker was placed outside of the an-
notated lesion margin were not included in the analysis and
regarded as a false negative (missed cancer). By doing so,
readers are not rewarded for a recall based on a false-
positive finding accidentally occurring in a malignant case.
We compared the AUCs for both reading modes for each
reader individually and also pooled over all readers (random
readers, random cases). Reading time was compared for
each reader individually by using Student’s t-test with
1000 bootstraps to determine the 95% CI and GEE for
Fig. 1 CAD-based minimum intensity projection (MinIP) integrated in a
multiplanar hanging protocol for ABUS that shows the conventional
ABUS planes. The top plane shows the transverse acquisitions, the
lower left plane the coronal reconstructions, and the lower right plane
the sagittal reconstruction. The MinIP (bottom row in the middle) is a
2D image where lower intensity regions in the 3D ABUS volume are
enhanced as dark spots. By clicking on the dark spot, the 3D multiplanar
hanging automatically snaps to the corresponding 3D location. The CAD
marks (coloured square) are displayed on the MinIP
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pooled data. Only the readings recorded within the 95th
percentile were included in the analysis to correct for inac-
tivity of the reader during the reading sessions.
The ROC analyses were performed using MRMC software
(JAFROC, version 4.2.1). The GEE was performed using the
‘geese’ function in the ‘geepack’ package in R (v. 3.2.3, R
Foundation for Statistical Computing, Vienna, Austria). All
other analyses were performed with SPSS statistics 20.0
(IBM Statistics, Armonk, NY).
Results
Patient characteristics
Table 1 summarises the patient characteristics in women
with breast cancer and Table 2 summarises patient char-
acteristics of women with a Bnormal^ or Bbenign^
ABUS examination.
Screening performance
Figure 2 and Table 3 summarise the screening perfor-
mance per reader. On average, the sensitivity of unaided
conventional ABUS reading (84%, 95% CI 78-88) was
similar to the sensitivity in the CAD-based ABUS reading
protocol (84%, 95% CI 79-89) (p = 0.90). Nevertheless,
half of the readers detected more cancers with CAD,
while only two readers detected fewer cancers using the
CAD-based reading protocol. In the CAD-based readings
6 out of 8 readers placed markers on a total of 11 lesions
that were actually malignant, but still classified them as
benign (BI-RADS 2). In the unaided ABUS reading this
happened only in four readers and a total of five malig-
nant lesions. Hence CAD helped in the detection of addi-
tional cancers but could not always induce an adequate
classification by the readers.
The average specificity for conventional ABUS reading
was 67% (95% CI 64-70) and this increased to 71% (95%
CI 68-75) in the CAD-based reading strategy, although this
did not reach statistical significance (p = 0.08). The PPV was
on average 13.6% higher for the CAD-based ABUS reading
(50.0%, 95% CI 45-55) compared to the conventional ABUS
reading (44.0%, 95% CI 39-49) (also not significant, p =
0.07). Overall, seven out of eight readers had higher specific-
ity and PPV with CAD than without. Specificity was signifi-
cantly higher in three out of eight readers (readers 1, 4, and 6;
Table 3). Nevertheless, the AUCs did not statistically differ
between the conventional ABUS reading and the CAD-based
workflow (0.82, 95% CI 0.73-0.92 and 0.83, 95% CI 0.75-
0.92, respectively) (p = 0.53) (Fig. 3).
Reading time
Table 4 summarises the reading time for each individual read-
er. On average, reading unilateral ABUS examinations using
CAD software decreases the overall reading time by 24.9 s/
case (SE 3.43; p < 0.001) (Fig. 4), which is a reduction of
15.7%. All readers were faster using CAD software (range,
3.1%-26.3%). In six out of eight readers, the CAD-based
workflow was significantly faster.
The average reading time for malignant cases decreased by
12.1% (20.5 s/case, SE 6.97, p = 0.003), for benign cases by
17.3% (28.2 s/case, SE 6.77, p ≤ 0.001), and for normal cases
by 16.8% (25.3 s/case, SE 4.76) (p ≤ 0.001).
Discussion
Our study shows that CAD software for ABUS can help radi-
ologists to evaluate ABUS examinations more efficiently.
Radiologists who screen for breast cancer may use CAD soft-
ware to evaluate batches of ABUS examinations 15.7% faster,
without decreasing their performance in terms of cancer de-
tection. Interestingly, the higher specificity and PPV of the
CAD-based reading mode suggest that the use of CAD soft-
ware for ABUS may help radiologists avoid unnecessary re-
calls of healthy women, albeit this did not reach statistical
significance. Our results might facilitate further implementa-
tion of ABUS. Supplemental ABUS in women with
mammographically dense breasts helps radiologists detect
early stage cancers that are occult on mammography
[11–13]. Supplemental US screening reduces the interval can-
cer rate in women with dense breasts [2, 21], which in general
is associated with improved outcome [6]. Unfortunately, 31%
of cancers in supplemental US screening are found to be al-
ready visible on a prior screening US examination and could
still have been detected earlier [22]. Reasons for non-detection
in WBUS screening are usually misinterpretation and over-
sight errors. In our study, oversight errors in malignant cases
were more often observed in conventional ABUS reading than
in the CAD-based reading. In fact, half of the readers detected
and correctly classified more cancers in the CAD-based read-
ings than in conventional ABUS reading. Nevertheless, of the
missed cancers several were still marked by six readers in the
CAD-based reading, but wrongly classified as benign.
Therefore, it appears that the CAD software has the potential
to prevent oversight errors in ABUS but might require further
development to also aid in characterising lesions. Also the
very limited experience all readers had with the CAD system
might have partly contributed to the misclassification of ma-
lignant lesions.
Supplemental ABUS has been shown to increase the recall
rate in breast cancer screening programmes [11, 13]. The im-
plementation of an intelligent MinIP into the reading
3000 Eur Radiol (2018) 28:2996–3006
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environment therefore also aims at improvement of specifici-
ty. The MinIP uses the greyscale contrast in B-mode ultra-
sound between lesions and healthy tissue to summarise the
3D volume in a 2D image; hence normal tissue appears
lighter than cancers that show up as dark spots on the
MinIP. Moreover the CAD software also enhances the
more suspicious regions by lowering the intensity of the
lesion on the MinIP and strengthening the coronal re-
traction sign, which is highly suggestive of breast can-
cer in ABUS [23]. Consequently, the MinIP points out
relevant lesions and reduces the suspiciousness of irrel-
evant regions in ABUS volumes. Our study indicates
that using this CAD software might indeed decrease
unnecessary recalls in ABUS by improving the specific-
ity and PPV of radiologists. Although the overall results
were not significant, a positive effect was still seen in
seven out of eight readers. Whether ABUS CAD soft-
ware in actual supplemental screening truly helps to
decrease the recall rate and improve radiologist’s speci-
ficity still needs to be investigated prospectively.
In a previous pilot study, we investigated the effect of CAD
software for ABUS on the screening performance of readers
when screening for breast cancer [24]. Our previous study
showed that concurrent reading CAD software may improve
the accuracy of radiologists for evaluation of single ABUS
volumes. In the current study, the CAD software was
Fig. 2 Increment in sensitivity
and specificity per reader after
subtracting the sensitivity of the
specificity of the conventional
ABUS reading session from the
CAD-based workflow reading
session. Ideally all readers
perform within the upper right
quadrant
Table 2 Characteristics of
women with an ABUS
examination labelled as ‘benign’
and ‘normal’
Mean age (SD) N symptomatic:screening Mean size (SD)
Normal cases (n = 60) 42.0 (9.5) 4:56 N/A
Benign cases total (n = 30) 44.9 (9.1) 15:15 12.4 (5.1)
Fibroadenoma (n = 12) 42.9 (5.3) 7:5 12.4 (5.7)
Fibrosis/adenosis (n = 5) 43.6 (6.3) 1:4 10.2 (4.1)
Cystic lesions (n = 5) 46.6 (8.8) 3:2 14.8 (7.8)
Other benign breast tissue (n = 5) 54.6 (13.0) 3:2 12.2 (1.9)
Papilloma (n = 2) 38.5 (9.2) 1:1 14.0 (2.8)
Complex sclerosing lesion (n = 1) 30.0 0:1 8.0 (0.0)
SD Standard deviation
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implemented into a specific CAD-based screening workflow
to boost the reading speed during batch reading of whole-
breast ABUS examinations. The purpose of this study was
therefore to investigate the effect of CAD software on the
efficiency rather than on the accuracy. In addition, this study
was performed using whole-breast examinations only from
women with heterogeneously dense or extremely dense
breasts, thus creating a data set that is representative for
supplementary screening with ABUS in dense breasts.
The mean reading time of a unilateral ABUS examina-
tion with an average of three volumes per breast with-
out CAD software in our study was 158.3 s, which is in
line with previously reported 3-9 min for a bilateral
WBUS examination [11, 16, 25]. However, our study
data set was enriched with cancers and suspicious be-
nign cases, which likely increases the reading time per
case. Our CAD-based reading workflow decreased the
average reading time with 15.7% to 133.4 s per unilat-
eral ABUS examination. The improvement in reading
speed was higher in normal and benign cases than in
malignant cases. We therefore expect that this gain in
efficiency in a true screening setting could be higher
than in our study.
Navigation of the ABUS examinations using the CAD-
enhanced MinIP can be performed relatively quickly. But
in our study the readers were instructed to evaluate all
dark spots and CAD marks in the MinIP and subsequently
also scan the coronal reconstructions of the ABUS vol-
umes. As a consequence our instructions prolonged the
reading time in the CAD-based reading sessions. Most
breast radiologists are familiar with the concept of
summarising relevant information of 3D breast imaging
in a 2D image, as is common practice in tomosynthesis
(synthetic mammogram) and in dynamic contrast-
enhanced breast MRI [maximum intensity projections
(MIP)]. Kuhl et al. reported that looking only at MIPs
is a reliable and fast (3-30 s per case) approach to
breast cancer screening with MRI [26]. The CAD-
enhanced MinIP in our study could theoretically be used
in a similar way, thus further reducing the reading time
required per ABUS volume. However, future studies
need to elucidate the effect this may have on the sensi-
tivity of ABUS.
Our study has limitations. We did not show corre-
sponding mammograms with the ABUS examinations
although these modalities are complementary in most
screenings regimes of women with dense breasts and
this might positively or negatively affect the screening
performance. Furthermore, we enriched the data set with
benign and malignant lesions from both screening and
diagnostic examinations to increase the power in this
study. By doing so, our study data set does not
Fig. 3 Alternative free-response
receiver-operating characteristic
curves for conventional ABUS
reading (striped intervals) and
computer-aided detection based
workflow reading (straight line).
No statistical difference is
observed between the areas under
the curves
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represent clinical practice where the prevalence of be-
nign and malignant lesions is lower. Finally, multiple
readers had little experience with ABUS and all readers
were inexperienced with the CAD software package that
we implemented in our screening environment, which
may have negatively affected the screening performance
and reading time.
In conclusion, our study shows that the CAD software de-
veloped for ABUS has the potential to improve the efficiency
of reading ABUS by significantly improving the reading
speed without decreasing the screening performance. Further
research is warranted in a prospective study to investigate the
effect of CAD on breast cancer detection, screening recalls,
and the interval cancer rate in screening programmes.
Table 4 Average reading time per reader for both conventional ABUS reading and reading the CAD-based reading workflow
Reader (years
experience ABUS)
Average reading
time ABUS (s)
95% CI (low, high) Average reading time
CAD-ABUS (s)
95% CI
(low, high)
Percentage
decrease
p value
1 (5) 171.2 156.5 186.5 166.0 150.4 181.0 3.1 0.56
2 (8) 145.4 132.4 159.1 136.1 124.5 149.6 6.5 0.24
3 (0) 146.7 132.6 162.2 123.4 113.0 134.3 15.9 < 0.001
4 (5) 175.2 158.7 190.8 140.8 130.2 150.1 19.7 0.001
5 (5) 101.2 95.7 108.4 91.2 84.7 97.7 9.9 0.008
6 (5) 138.6 127.1 151.1 110 100.1 119.4 20.6 0.001
7 (0) 217.2 197.9 236.2 160.1 148.0 172.3 26.3 0.001
8 (0) 173.3 173.3 185.2 140.9 132.3 150.0 18.7 0.001
Pooled
Average 158.3 153.0 163.6 133.4 129.2 137.6 15.7 < 0.001
Normal 151.0 143.6 158.4 125.7 120.0 131.4 16.8 < 0.001
Benign 163.0 152.6 173.3 134.8 126.4 143.1 17.3 < 0.001
Malignant 169.3 158.8 180.0 148.8 140.2 157.5 12.1 0.003
All readers were faster with CAD software. Six of eight readers were significantly faster ABUS Automated breast ultrasound
CAD Computer-aided detection software
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Fig. 4 Histograms for reading time needed to read all cases in a conventional ABUS protocol (striped interval) and for reading in a CAD-based workflow
protocol (straight)
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